BioSpace News Archive

Drug Development

Merrimack Pharmaceuticals Inc. Announces Oral Presentation Of Additional Analyses Of MM-398 Phase 3 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium

January 8, 2015
·
3 min read
Drug Development

Karyopharm Therapeutics Announces Orphan Designation Granted By FDA For Selinexor (KPT-330) In Multiple Myeloma

January 8, 2015
·
5 min read
Business

Stemline Therapeutics, Inc. In-Licenses Novel Oral Small Molecule Nuclear Transport Inhibitor Targeting XPO1

January 8, 2015
·
4 min read
Business

Helsinn And Pharmacosmos A/S Enter Into An Exclusive License Agreement For The Development And Commercialization Of Monofer® In US

January 8, 2015
·
5 min read
Pharm Country

Stemline Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock

January 8, 2015
·
5 min read
Business

Ultragenyx Pharmaceuticals Announces License Of Intellectual Property Related To The Treatment Of Huntington’s Disease With Triheptanoin

January 8, 2015
·
5 min read
BioForest

CTI BioPharma Announces 2015 Outlook And Recent Drug Portfolio Progress

January 8, 2015
·
8 min read
Business

Egalet Acquires/Licenses Two Innovative Approved Pain Products

January 8, 2015
·
13 min read
Bio NC

Cempra Pharmaceuticals, Inc. Prices Public Offering of Common Stock

January 8, 2015
·
4 min read
FDA Grants Fast Track Designation To Debiopharm’s Antibiotic Debio 1450

January 8, 2015
·
2 min read